Trial Outcomes & Findings for Single Breath Hold Abdominal MRI (NCT NCT02434471)

NCT ID: NCT02434471

Last Updated: 2018-07-02

Results Overview

Three investigators will independently evaluate MRI examinations. They will assign motion scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no motion artifact; 2 = minimal motion artifact, no effect on diagnostic quality; 3 = moderate motion artifact with some, but not severe, effect on diagnostic quality; 4 = severe motion artifact, images degraded but interpretable; and 5 = extensive motion artifact, images nondiagnostic.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

54 participants

Primary outcome timeframe

During MRI, up to 60 minutes

Results posted on

2018-07-02

Participant Flow

Subjects did not continue participation in the study if their scans were cancelled or rescheduled outside of their hospitalization. Twenty enrolled subjects fell into this category.

Participant milestones

Participant milestones
Measure
Conventional Breath-held LAVA Then Respiratory Triggered Exams
All study subjects underwent an MRI exam including conventional breath-held LAVA imaging pre- and post-contrast, as well as respiratory-triggered DISCO imaging pre- and post-contrast
Overall Study
STARTED
34
Overall Study
COMPLETED
25
Overall Study
NOT COMPLETED
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Conventional Breath-held LAVA Then Respiratory Triggered Exams
All study subjects underwent an MRI exam including conventional breath-held LAVA imaging pre- and post-contrast, as well as respiratory-triggered DISCO imaging pre- and post-contrast
Overall Study
Physician Decision
9

Baseline Characteristics

Single Breath Hold Abdominal MRI

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Subjects
n=25 Participants
All study subjects
Age, Continuous
57.94 years
STANDARD_DEVIATION 12.7 • n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=5 Participants
Race (NIH/OMB)
White
19 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
25 Participants
n=5 Participants

PRIMARY outcome

Timeframe: During MRI, up to 60 minutes

Population: The same 25 subjects were used in both groups.

Three investigators will independently evaluate MRI examinations. They will assign motion scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no motion artifact; 2 = minimal motion artifact, no effect on diagnostic quality; 3 = moderate motion artifact with some, but not severe, effect on diagnostic quality; 4 = severe motion artifact, images degraded but interpretable; and 5 = extensive motion artifact, images nondiagnostic.

Outcome measures

Outcome measures
Measure
Breath Hold Liver Acquisition With Volume Acquisition (LAVA)
n=25 Participants
Subjects will undergo abdominal MRI with LAVA with conventional breath holds (typically four or more breath holds) per standard of care.
Respiratory-triggered T1w DISCO LAVA
n=25 Participants
The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required. Respiratory-triggered T1w DISCO LAVA: The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required. 1. Respiratory-triggered T1w DISCO LAVA precontrast 2. Respiratory-triggered T1w DISCO LAVA in the portal venous phase 3. Respiratory-triggered T1w DISCO LAVA in the equilibrium phase
Motion Artifact Scores
1.8 scores on a scale
Standard Deviation 1.0
2.4 scores on a scale
Standard Deviation 0.9

PRIMARY outcome

Timeframe: During MRI, up to 60 minutes

Population: The same 25 subjects were used for each group.

Three investigators will independently evaluate MRI examinations. They will assign noise scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no noise artifact; 2 = minimal noise artifact, no effect on diagnostic quality; 3 = moderate noise artifact with some, but not severe, effect on diagnostic quality; 4 = severe noise artifact, images degraded but interpretable; and 5 = severe noise artifact, images nondiagnostic.

Outcome measures

Outcome measures
Measure
Breath Hold Liver Acquisition With Volume Acquisition (LAVA)
n=25 Participants
Subjects will undergo abdominal MRI with LAVA with conventional breath holds (typically four or more breath holds) per standard of care.
Respiratory-triggered T1w DISCO LAVA
n=25 Participants
The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required. Respiratory-triggered T1w DISCO LAVA: The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required. 1. Respiratory-triggered T1w DISCO LAVA precontrast 2. Respiratory-triggered T1w DISCO LAVA in the portal venous phase 3. Respiratory-triggered T1w DISCO LAVA in the equilibrium phase
Noise Scores
1.7 scores on a scale
Standard Deviation 0.6
1.8 scores on a scale
Standard Deviation 0.7

Adverse Events

All Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mustafa R. Bashir, M.D.

Duke University

Phone: 919-684-7366

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place